Literature DB >> 16249934

Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.

T R Field1, A White, J S Elborn, M M Tunney.   

Abstract

Pseudomonas aeruginosa, the predominant causative pathogen of chronic lung infection in patients with cystic fibrosis, may grow under anaerobic conditions as biofilms in the lungs of cystic fibrosis patients. To determine if growth under anaerobic conditions affects the antimicrobial susceptibility of P. aeruginosa, the susceptibility of clinical isolates of P. aeruginosa grown planktonically and as biofilms to a range of antibiotics was determined. Growth under anaerobic conditions did not reduce the ability of ceftazidime, meropenem, aztreonam, piperacillin, or piperacillin/tazobactam to inhibit planktonic growth, with MIC50 values for these antibiotics remaining unchanged or decreasing. However, tobramycin was less effective at inhibiting planktonic bacterial growth under anaerobic conditions, with the MIC50 of tobramycin increasing twofold. Growth under anaerobic conditions also decreased the bactericidal activity of tobramycin, with the MBC50 of tobramycin increasing fourfold. The killing kinetics of tobramycin was also examined under aerobic and anaerobic conditions for selected isolates. When isolates 6A and 12A were grown aerobically, concentration-dependent decreases in total viable count were apparent with tobramycin. In contrast, when these isolates were grown anaerobically, tobramycin at the same concentrations did not decrease the total viable count. When isolates were grown as biofilms under both aerobic and anaerobic conditions, isolate- and concentration-dependent differences in killing of the biofilms by tobramycin were apparent. However, tobramycin at concentrations up to 128 mg/l was unable to eradicate biofilms of any of the isolates tested, whether biofilms were grown aerobically or anaerobically. These results show that oxygen limitation may reduce, in a strain-dependent manner, the susceptibility to tobramycin of P. aeruginosa grown planktonically and as biofilms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249934     DOI: 10.1007/s10096-005-0031-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen.

Authors:  D J Hassett
Journal:  J Bacteriol       Date:  1996-12       Impact factor: 3.490

3.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Authors:  Sang Sun Yoon; Robert F Hennigan; George M Hilliard; Urs A Ochsner; Kislay Parvatiyar; Moneesha C Kamani; Holly L Allen; Teresa R DeKievit; Paul R Gardner; Ute Schwab; John J Rowe; Barbara H Iglewski; Timothy R McDermott; Ronald P Mason; Daniel J Wozniak; Robert E W Hancock; Matthew R Parsek; Terry L Noah; Richard C Boucher; Daniel J Hassett
Journal:  Dev Cell       Date:  2002-10       Impact factor: 12.270

Review 4.  Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Authors:  Daniel J Hassett; John Cuppoletti; Bruce Trapnell; Sergei V Lymar; John J Rowe; Sang Sun Yoon; George M Hilliard; Kislay Parvatiyar; Moneesha C Kamani; Daniel J Wozniak; Sung Hei Hwang; Timothy R McDermott; Urs A Ochsner
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

Review 5.  An overview of the pathogenesis of cystic fibrosis lung disease.

Authors:  R C Boucher
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

6.  Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

Authors:  S D Aaron; W Ferris; D A Henry; D P Speert; N E Macdonald
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

7.  Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo.

Authors:  P Davey; M Barza; M Stuart
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

8.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

9.  The assimilatory and dissimilatory nitrate reductases of Pseudomonas aeruginosa are encoded by different genes.

Authors:  S R Sias; A H Stouthamer; J L Ingraham
Journal:  J Gen Microbiol       Date:  1980-05

10.  Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.

Authors:  Giorgia Borriello; Erin Werner; Frank Roe; Aana M Kim; Garth D Ehrlich; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

View more
  22 in total

1.  Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens.

Authors:  Mona Jasmine R Ahonen; Jamie M Dorrier; Mark H Schoenfisch
Journal:  ACS Infect Dis       Date:  2019-06-11       Impact factor: 5.084

2.  Antibiotic resistance in an in vitro subgingival biofilm model.

Authors:  M J Sedlacek; C Walker
Journal:  Oral Microbiol Immunol       Date:  2007-10

3.  Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.

Authors:  Philip S Stewart; Ben White; Laura Boegli; Timothy Hamerly; Kerry S Williamson; Michael J Franklin; Brian Bothner; Garth A James; Steve Fisher; Francisco G Vital-Lopez; Anders Wallqvist
Journal:  J Bacteriol       Date:  2019-10-21       Impact factor: 3.490

4.  Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa.

Authors:  Kristen N Kindrachuk; Lucía Fernández; Manjeet Bains; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

5.  Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.

Authors:  Gerard McCaughey; Deirdre F Gilpin; Thamarai Schneiders; Lucas R Hoffman; Matt McKevitt; J Stuart Elborn; Michael M Tunney
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

6.  Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei.

Authors:  Mohamad A Hamad; Chad R Austin; Amanda L Stewart; Mike Higgins; Andrés Vázquez-Torres; Martin I Voskuil
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

7.  Effects of cerium oxide nanoparticles on bacterial growth and behaviors: induction of biofilm formation and stress response.

Authors:  Yi Xu; Chao Wang; Jun Hou; Peifang Wang; Guoxiang You; Lingzhan Miao
Journal:  Environ Sci Pollut Res Int       Date:  2019-02-05       Impact factor: 4.223

8.  Antibacterial Action of Nitric Oxide-Releasing Chitosan Oligosaccharides against Pseudomonas aeruginosa under Aerobic and Anaerobic Conditions.

Authors:  Katelyn P Reighard; Mark H Schoenfisch
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

9.  Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.

Authors:  Sebastian Kirchner; Joanne L Fothergill; Elli A Wright; Chloe E James; Eilidh Mowat; Craig Winstanley
Journal:  J Vis Exp       Date:  2012-06-05       Impact factor: 1.355

10.  Nanotoxicity of 2D Molybdenum Disulfide, MoS2, Nanosheets on Beneficial Soil Bacteria, Bacillus cereus and Pseudomonas aeruginosa.

Authors:  Michael Bae; Jun Kyun Oh; Shuhao Liu; Nirup Nagabandi; Yagmur Yegin; William DeFlorio; Luis Cisneros-Zevallos; Ethan M A Scholar
Journal:  Nanomaterials (Basel)       Date:  2021-05-31       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.